61 related articles for article (PubMed ID: 6769305)
1. Sodium valproate.
Kupferberg HJ
Adv Neurol; 1980; 27():643-54. PubMed ID: 6769305
[No Abstract] [Full Text] [Related]
2. Previous prolonged clonic seizures diminish antiepileptic activity of valproate against pentetrazol-evoked convulsions.
Haberek G; Tomczyk T; Urbańska EM
Pol J Pharmacol; 2001; 53(1):81-2. PubMed ID: 11785918
[TBL] [Abstract][Full Text] [Related]
3. Antagonism by classical antiepileptics and sodium valproate of cefazolin in induced experimental epilepsy in rats.
Nistico G; De Sarro GB; Rotiroti D; Silvestri R; Marmo E
Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):429-44. PubMed ID: 6775359
[TBL] [Abstract][Full Text] [Related]
4. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Mohamed M; Czuczwar SJ
Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
[TBL] [Abstract][Full Text] [Related]
5. Anti-epileptic properties of sodium valproate in rat amygdaloid kindling [proceedings].
Salt TE; Tulloch IF; Walter DS
Br J Pharmacol; 1980 Jan; 68(1):134P. PubMed ID: 6766768
[No Abstract] [Full Text] [Related]
6. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
7. EEG quantification of drug level effects in monkey model of partial epilepsy.
Lockard JS; Levy RH; DuCharme LL; Congdon WC
Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():487-503. PubMed ID: 6819124
[No Abstract] [Full Text] [Related]
8. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
[TBL] [Abstract][Full Text] [Related]
9. Ethosuximide and valproate display high efficacy against lindane-induced seizures in mice.
Kaminski RM; Tochman AM; Dekundy A; Turski WA; Czuczwar SJ
Toxicol Lett; 2004 Dec; 154(1-2):55-60. PubMed ID: 15475178
[TBL] [Abstract][Full Text] [Related]
10. Influence of SIB 1893, a selective mGluR5 receptor antagonist, on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.
Borowicz KK; Piskorska B; Łuszczki J; Czuczwar SJ
Pol J Pharmacol; 2003; 55(5):735-40. PubMed ID: 14704469
[TBL] [Abstract][Full Text] [Related]
11. The influence of ethanol on pentetrazol-induced seizures and anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice.
Kleinrok Z; Dziki M; Janczarek T
Pol J Pharmacol; 1993; 45(4):361-8. PubMed ID: 8118481
[TBL] [Abstract][Full Text] [Related]
12. [Anticonvulsant and neurotoxic effects of various combinations of phenobarbital, diazepam, sodium valproate, and 1,4-dihydropyridine ryodipine].
Karpova MN; Kryzhanovskiĭ GN; Abrosimov IIu
Biull Eksp Biol Med; 1994 Jul; 118(7):14-6. PubMed ID: 7919262
[No Abstract] [Full Text] [Related]
13. Effect of theophylline on diazepam and sodium valproate protection in pentylenetetrazole - kindled seizures in rats.
Gupta YK; Malhotra J
Indian J Physiol Pharmacol; 1997 Jul; 41(3):280-4. PubMed ID: 10232774
[TBL] [Abstract][Full Text] [Related]
14. [The effect of difenin, valproate and phenobarbital on the development of an epileptiform seizure attack in Krushinskiĭ-Molodkina rats].
Fedotova IB; Semiokhina AF; Fless DA; Arkhipova GV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(6):1104-8. PubMed ID: 9054163
[TBL] [Abstract][Full Text] [Related]
15. [The comparative action of calcium valproate (Convulsofin) with sodium valproate and free acid].
Morgenstern E; Stattmann A; Dove B; Göres E
Pharmazie; 1984 Dec; 39(12):870-1. PubMed ID: 6442425
[No Abstract] [Full Text] [Related]
16. N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Kocharov SL; Czuczwar SJ
Neurosci Res; 2009 Jul; 64(3):267-72. PubMed ID: 19447295
[TBL] [Abstract][Full Text] [Related]
17. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats.
Sobaniec W; Sobaniec-Lotowska M
Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038
[TBL] [Abstract][Full Text] [Related]
18. Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine.
Uma Devi P; Pillai KK; Vohora D
Fundam Clin Pharmacol; 2006 Jun; 20(3):247-53. PubMed ID: 16671959
[TBL] [Abstract][Full Text] [Related]
19. Actions of sodium valproate on the central nervous system.
Tunnicliff G
J Physiol Pharmacol; 1999 Sep; 50(3):347-65. PubMed ID: 10574466
[TBL] [Abstract][Full Text] [Related]
20. Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice.
Srivastava AK; Gupta YK
Indian J Physiol Pharmacol; 2001 Oct; 45(4):475-80. PubMed ID: 11883156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
